Platelet-activating factor and liver metastasis of colorectal cancer [1]

International Journal of Cancer

Volumn 113, Issue 3, 2005, Pages 503-505

  Denizot, Yves ^a   Descottes, Bernard ^b   Truffinet, Véronique ^a   Valleix, Denis ^b   Labrousse, François ^b   Mathonnet, Muriel ^b  

^a CNRS   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; VASCULOTROPIN;

COLORECTAL CANCER; COMPARATIVE STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; HUMAN; LETTER; LIVER METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANTIGENS, HUMAN PLATELET; COLON; COLORECTAL NEOPLASMS; EPITOPES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECTUM; RNA, MESSENGER;

EID: 11144283115     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20585     Document Type: Letter

References (36)

1. Denizot Y, Guglielmi L, Donnard M, Trimoreau F. Platelet-activating factor and normal or leukaemic haematopoiesis. Leuk Lymphom 2003;44:775-82.
2. Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta 1996;1301:161-73.
3. Izumi T, Shimizu T. Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta 1995;1259:317-33.
4. Youlyouz I, Magnoux E, Guglielmi L, Denizot Y. Expression of a splice variant of the platelet-activating factor receptor transcript 2 in various human cancer cell lines. Med Inflamm 2002;11:329-31.
5. Maggi M, Bonaccorsi L, Finetti G, Carloni V, Muratori M, Laffi G, Forti G, Serio M, Baldi E. Platelet-activating factor mediates an autocrine proliferative loop in endometrial adenocarcinoma cell line HEC-1A. Cancer Res 1994;54:4777-84.
6. Bussolati B, Biancone L, Cassoni P, Russo S, Rola-Pleszczynski M, Montrucchio G, Camussi G. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neoangiogenesis. Am J Pathol 2000;157:1713-25.
7. Mannori G, Barletta E, Mugnai G, Ruggieri S. Interaction of tumor cells with vascular endothelia: role of platelet-activating factor. Clin Exp Metastasis 2000;18:89-96.
8. Tripathi YB, Kandala JC, Guntaka RV, Lim RW, Shukla SD. Platelet-activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells. Life Sci 1991;49:1761-7.
9. Montrucchio G, Lupia E, Battaglia E, Del Sorbo L, Boccellino M, Biancone L, Emanuelli G, Camussi G. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol 2000;20:80-8.
10. Fallani A, Mannori G, Ruggieri S. Composition of ether-linked subclasses of glycerophospholipids in clones with a different metastatic potential isolated from a murine fibrosarcoma line (T3 cells). Int J Cancer 1995;62:230-2.
11. Im SY, Ko HM, Kim JW, Lee HK, Ha TY, Lee HB, Oh SJ, Bai S, Chung KC, Lee YB, Kang HS, Chun SB. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res 1996;56:2662-5.
12. Pitton C, Lanson M, Besson P, Fetissoff F, Lansac J, Benveniste J. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. J Natl Cancer Inst 1989;81:1298-302.
13. Denizot Y, Gainant A, Guglielmi L, Bouvier S, Cubertafond P, Mathonnet M. Tissu concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients. Oncogene 2003;22:7222-4.
14. Lombard MN, Izzo AA, Benhaddi M, Natour J, Benveniste J. Liver and plasma concentrations in paf-acether and its precursors after partial hepatectomy. Cell Prolif 1996;29:33-41.
15. Howard KM, Miller JE, Miwa M, Olson MS. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 1997;272:27543-8.
16. Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM. Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J Biol Chem 1991;266:16667-73.
17. Denizot Y, Desplat V, Drouet M, Bertin F, Melloni B. Is there a role of platelet-activating factor in human lung cancer? Lung Cancer 2001;33:195-202.
18. Mutoh H, Ishii S, Izumi T, Kato S, Shimizu T. Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B. Biochem Biophys Res Commun 1994;205:1137-42.
19. Wang H, Tan X, Chang H, Huang W, Gonzalez-Crussi F, Hsueh W. Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. Immunology 1999;97:447-54.
20. Wang H, Tan X, Chang H, Gonzalez-Crussi F, Remick DG, Hsueh W. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J 1997;322:603-8.
21. Okahara K, Sun B, Kawasaki T, Monden M, Kambayashi J. Expression of platelet-activating factor receptor transcript-2 is induced by shear stress in HUVEC. Prostaglandins Other Lipid Mediat 1998;55:323-9.
22. 2+ signalling and mRNA expression of platelet-activating factor receptor by estradiol in human uterine endometrial cells. Adv Exp Med Biol 1996;416:95-100.
23. Sirois MG, Edelman ER. VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol 1997;272:H2746-56.
24. Chai YC, Binion DG, Chisolm GM. Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol 2000;279:H1830-8.
25. Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG, Hunt JD. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2. and Src in human umbilical vein endothelial cells. J Biol Chem 2002;277:21237-45.
26. Ko HM, Seo KH, Han SJ, Ahn YA, Choi IH, Koh GY, Lee HK, Ra MS, Im SY. Nuclear factor kB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002;62:1809-14.
27. Montrucchio G, Sapino A, Bussolati B, Ghisolfi G, Rizea-Savu S, Silvestro L, Lupia E, Camussi G. Potential angiogenic role of platelet-activating factor in human breast cancer. Am J Pathol 1998;153:1589-96.
28. Landriscina M, Cassano A, Ratto C, Longo R, Ippoliti M, Palazzotti B, Crucitti F, Barone C. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 1998;78:765-70.
29. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995;95:1789-97.
30. Kondo Y, Arii S, Mori A, Furutani M, Chiba T, Imamura M. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin Cancer Res 2000;6:622-30.
31. Miyake H, Hara I, Yoshimura K, Eto H, Arakawa S, Wada S, Chihara K. Kamidonos S. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential. Cancer Res 1996;56:2440-5.
32. Kang YH, Kim WH, Park MK, Han BH. Antimetastatic and antitumor effects of benzoquinonoid AC7-1 from ardisia crispa. Int J Cancer 2001;93:736-40.
33. Furihata T, Kawamata H, Kubota K, Fujimori T. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis. Int J Mol Med 2002;9:353-8.
34. Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PAE, Robinson BA, Fox SB. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 2003;200:183-94.
35. Hansel DE, Rahman A, Hermans J, de Krijger RR, Ashfaq R, Yeo CJ, Cameron JL, Maitra A. Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression. Mod Pathol 2003;16:652-9.
36. Biancone L, Cantaluppi V, Del Sorbo L, Russo S, Tjoelker LW, Camussi G. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. Clin Cancer Res 2003;9:4214-20.